NCT00653757View on ClinicalTrials.gov

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

goserelin acetate

DRUG

leuprolide acetate

RADIATION

image-guided radiation therapy

RADIATION

intensity-modulated radiation therapy

Trial Locations (1)

Unknown

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00653757 - Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | Biotech Hunter | Biotech Hunter